$SSY
SUNLINK HEALTH SYSTEMS INC

2016 Q1 Form 10-Q Financial Statement

#000119312516589719 Filed on May 13, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $16.21M $19.29M
YoY Change -15.98% -36.21%
Cost Of Revenue $761.0K $1.382M
YoY Change -44.93% 7.21%
Gross Profit $15.44M $17.91M
YoY Change -13.75% -38.15%
Gross Profit Margin 95.3% 92.83%
Selling, General & Admin $9.340M $14.22M
YoY Change -34.32% 0.64%
% of Gross Profit 60.48% 79.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $480.0K $602.0K
YoY Change -20.27% -22.12%
% of Gross Profit 3.11% 3.36%
Operating Expenses $11.78M $17.46M
YoY Change -32.53% -2.18%
Operating Profit -$1.187M -$285.0K
YoY Change 316.49% -38.71%
Interest Expense $211.0K $213.0K
YoY Change -0.94% -8.97%
% of Operating Profit
Other Income/Expense, Net $1.960M $0.00
YoY Change -100.0%
Pretax Income -$1.393M -$485.0K
YoY Change 187.22% -28.78%
Income Tax -$1.000K -$169.0K
% Of Pretax Income
Net Earnings -$1.835M -$411.0K
YoY Change 346.47% -57.37%
Net Earnings / Revenue -11.32% -2.13%
Basic Earnings Per Share -$0.19 -$0.04
Diluted Earnings Per Share -$0.19 -$0.04
COMMON SHARES
Basic Shares Outstanding 9.443M shares 9.443M shares
Diluted Shares Outstanding 9.443M shares 9.443M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.900M $4.900M
YoY Change -20.41% 28.95%
Cash & Equivalents $3.889M $4.885M
Short-Term Investments
Other Short-Term Assets $2.400M $6.100M
YoY Change -60.66% -29.89%
Inventory $3.618M $3.936M
Prepaid Expenses
Receivables $8.500M $1.525M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.41M $24.93M
YoY Change -26.15% -11.12%
LONG-TERM ASSETS
Property, Plant & Equipment $21.85M $22.54M
YoY Change -3.03% -23.0%
Goodwill $461.0K $461.0K
YoY Change 0.0% 0.0%
Intangibles $2.731M $2.873M
YoY Change -4.94% -6.33%
Long-Term Investments
YoY Change
Other Assets $1.463M $1.522M
YoY Change -3.88% 2.98%
Total Long-Term Assets $26.51M $32.49M
YoY Change -18.42% -15.77%
TOTAL ASSETS
Total Short-Term Assets $18.41M $24.93M
Total Long-Term Assets $26.51M $32.49M
Total Assets $44.92M $57.42M
YoY Change -21.78% -13.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.975M $4.429M
YoY Change 12.33% -14.4%
Accrued Expenses $1.078M $5.400M
YoY Change -80.04% -8.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.123M $840.0K
YoY Change 867.02% -90.87%
Total Short-Term Liabilities $19.06M $10.70M
YoY Change 78.14% -55.31%
LONG-TERM LIABILITIES
Long-Term Debt $3.321M $11.47M
YoY Change -71.06% 35.74%
Other Long-Term Liabilities $566.0K $755.0K
YoY Change -25.03% -10.86%
Total Long-Term Liabilities $5.104M $13.22M
YoY Change -61.39% 22.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.06M $10.70M
Total Long-Term Liabilities $5.104M $13.22M
Total Liabilities $24.16M $23.92M
YoY Change 1.01% -31.15%
SHAREHOLDERS EQUITY
Retained Earnings $2.882M $15.64M
YoY Change -81.57% 10.63%
Common Stock $18.25M $18.20M
YoY Change 0.28% 285.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.80M $33.50M
YoY Change
Total Liabilities & Shareholders Equity $44.92M $57.42M
YoY Change -21.78% -13.81%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$1.835M -$411.0K
YoY Change 346.47% -57.37%
Depreciation, Depletion And Amortization $480.0K $602.0K
YoY Change -20.27% -22.12%
Cash From Operating Activities $630.0K $1.340M
YoY Change -52.99% -682.61%
INVESTING ACTIVITIES
Capital Expenditures $302.0K $258.0K
YoY Change 17.05% -23.21%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$340.0K -$260.0K
YoY Change 30.77% -27.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -130.0K -170.0K
YoY Change -23.53% 13.33%
NET CHANGE
Cash From Operating Activities 630.0K 1.340M
Cash From Investing Activities -340.0K -260.0K
Cash From Financing Activities -130.0K -170.0K
Net Change In Cash 160.0K 910.0K
YoY Change -82.42% -222.97%
FREE CASH FLOW
Cash From Operating Activities $630.0K $1.340M
Capital Expenditures $302.0K $258.0K
Free Cash Flow $328.0K $1.082M
YoY Change -69.69% -291.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Assets
Assets
57423000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4885000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4487000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9444000 shares
CY2016Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2016Q1 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9444000 shares
CY2016Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5104000
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9443408 shares
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7279000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5632000
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13529000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3189000
CY2016Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3321000
CY2016Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
36000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
566000
CY2016Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2000
CY2016Q1 us-gaap Long Term Debt
LongTermDebt
11444000
CY2016Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1689000
CY2016Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8123000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4975000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3455000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1078000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2882000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44919000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
4722000
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20759000
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33887000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19056000
CY2016Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11654000
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374000
CY2016Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8463000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1463000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
18410000
CY2016Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11600000
CY2016Q1 us-gaap Goodwill
Goodwill
461000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2440000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3889000
CY2016Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4655000
CY2016Q1 us-gaap Assets
Assets
44919000
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2731000
CY2016Q1 us-gaap Inventory Net
InventoryNet
3618000
CY2016Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
0
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21854000
CY2016Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55741000
CY2016Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
CY2016Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11918000
CY2016Q1 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
1217000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6903000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3587000
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9444000 shares
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2015Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9444000 shares
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12804000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13481000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3946000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11229000
CY2015Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
137000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
681000
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
64000
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
12045000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1479000
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
816000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4459000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5347000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15731000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57128000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
4722000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33560000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32259000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10764000
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374000
CY2015Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9625000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1520000
CY2015Q2 us-gaap Goodwill
Goodwill
461000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2642000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5974000
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4885000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54592000
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1967000
CY2015Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
14972000
CY2015Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
894000
CY2015Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9703000
CY2015Q2 us-gaap Assets
Assets
57128000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2837000
CY2015Q2 us-gaap Inventory Net
InventoryNet
3758000
CY2015Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1126000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22333000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
25092000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1292000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9481000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
995000
us-gaap Insurance Recoveries
InsuranceRecoveries
1000000
us-gaap Net Income Loss
NetIncomeLoss
153000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
562000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
13000
us-gaap Sales Revenue Net
SalesRevenueNet
68853000
us-gaap Interest Paid
InterestPaid
614000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-409000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-503000
us-gaap Operating Income Loss
OperatingIncomeLoss
2042000
us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-287000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4842000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
153000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
203000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1378000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
816000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6090000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1020000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1298000
us-gaap Interest Expense
InterestExpense
677000
us-gaap Cost Of Services
CostOfServices
3880000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5078000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9371000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
225000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
175000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
41000
us-gaap Supplies Expense
SuppliesExpense
5546000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
6060000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
591000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
32135000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
16253000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1817000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5084000
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-291000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7036000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
188000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
995000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
11000
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
64000
ssy Repayments Of Long Term Debt Discontinued Operations
RepaymentsOfLongTermDebtDiscontinuedOperations
411000
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
74913000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.36
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 2. &#x2013; Business Operations</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Business Operations</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc., through subsidiaries, owns businesses which are providers of healthcare services in certain markets in the United States. SunLink&#x2019;s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Healthcare Facilities Segment which is composed of two operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Three community hospital subsidiaries in two states with a total of 183 licensed beds;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to a corresponding SunLink community hospital; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Pharmacy Segment which is composed of four material service lines:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%">&#xA0;</td> <td valign="top" width="4%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the pharmacy business since 2008. The Pharmacy Segment currently is operated through Carmichael&#x2019;s Cashway Pharmacy, Inc. (&#x201C;Carmichael&#x201D;), a subsidiary of SunLink ScriptsRx, LLC.</p> </div>
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.33
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-291000
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
dei Trading Symbol
TradingSymbol
SSY
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.36
us-gaap Malpractice Insurance Description
MalpracticeInsuranceDescription
Claim made under its insurance policy covering, among other things, employee theft relating to misappropriation of funds by two now former employees over an eight year period beginning in 2006.
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1193000
us-gaap Insurance Recoveries
InsuranceRecoveries
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49000
us-gaap Supplies Expense
SuppliesExpense
4654000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
3692000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6189000
us-gaap Net Income Loss
NetIncomeLoss
-12849000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12523000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
12000
us-gaap Sales Revenue Net
SalesRevenueNet
60729000
us-gaap Interest Paid
InterestPaid
579000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-326000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-326000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5046000
us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-687000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
601000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12849000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
78000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5671000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6852000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
945000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2085000
us-gaap Interest Expense
InterestExpense
637000
us-gaap Cost Of Services
CostOfServices
3722000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-601000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5898000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
663000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Labor And Related Expense
LaborAndRelatedExpense
30787000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15582000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1778000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1193000
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
0
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7778000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
429000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1193000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
0
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
-100000
ssy Repayments Of Long Term Debt Discontinued Operations
RepaymentsOfLongTermDebtDiscontinuedOperations
0
ssy Number Of Hospital Facilities
NumberOfHospitalFacilities
3 Hospital
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
64421000
CY2015Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
1000000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
258000
CY2015Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
0
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-411000
CY2015Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-316000
CY2015Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
13000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
23351000
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-95000
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-144000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-285000
CY2015Q1 us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
10000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-411000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-485000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-169000
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
343000
CY2015Q1 us-gaap Interest Expense
InterestExpense
213000
CY2015Q1 us-gaap Cost Of Services
CostOfServices
1382000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3370000
CY2015Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
103000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12000
CY2015Q1 us-gaap Supplies Expense
SuppliesExpense
1702000
CY2015Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
1845000
CY2015Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-272000
CY2015Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
10729000
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6181000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
602000
CY2015Q1 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-55000
CY2015Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2696000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65000
CY2015Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
64000
CY2015Q1 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
25196000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.18
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.18
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
348000
CY2016Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
0
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1835000
CY2016Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1714000
CY2016Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
5000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
19975000
CY2016Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-121000
CY2016Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-121000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1508000
CY2016Q1 us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
128000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1835000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1714000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
302000
CY2016Q1 us-gaap Interest Expense
InterestExpense
211000
CY2016Q1 us-gaap Cost Of Services
CostOfServices
1138000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1844000
CY2016Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000
CY2016Q1 us-gaap Supplies Expense
SuppliesExpense
1347000
CY2016Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
759000
CY2016Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-21000
CY2016Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
9887000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5614000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
618000
CY2016Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2508000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
69000
CY2016Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
CY2016Q1 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
20734000

Files In Submission

Name View Source Status
0001193125-16-589719-index-headers.html Edgar Link pending
0001193125-16-589719-index.html Edgar Link pending
0001193125-16-589719.txt Edgar Link pending
0001193125-16-589719-xbrl.zip Edgar Link pending
d146081d10q.htm Edgar Link pending
d146081dex101.htm Edgar Link pending
d146081dex102.htm Edgar Link pending
d146081dex311.htm Edgar Link pending
d146081dex312.htm Edgar Link pending
d146081dex321.htm Edgar Link pending
d146081dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20160331.xml Edgar Link completed
ssy-20160331.xsd Edgar Link pending
ssy-20160331_cal.xml Edgar Link unprocessable
ssy-20160331_def.xml Edgar Link unprocessable
ssy-20160331_lab.xml Edgar Link unprocessable
ssy-20160331_pre.xml Edgar Link unprocessable